ChiCTR2000033314 版本V1.0 版本创建时间2020/05/27 22:13:39 中国临床试验注册中心

审核状态:

Project audit state:

通过审核

Successful

注册号:

Registration number:

ChiCTR2000033314 

最近更新日期:

Date of Last Refreshed on:

2020-05-27 22:11:53 

注册时间:

Date of Registration:

1990-01-01 00:00:00 

注册号状态:

预注册

Registration Status:

Prospective registration

注册题目:

待编辑(三)空气与二氧化碳对电子胃镜检查后患者舒适度及并发症比较:一项前瞻性随机对照研究

Public title:

Comparison of air and carbon dioxide on comfort and complications of patients after gastroscopy: a prospective randomized controlled trial

注册题目简写:

English Acronym:

研究课题的正式科学名称:

空气与二氧化碳对电子胃镜检查后患者舒适度及并发症比较:一项前瞻性随机对照研究

Scientific title:

Comparison of air and carbon dioxide on comfort and complications of patients after gastroscopy: a prospective randomized controlled trial

研究课题代号(代码):

Study subject ID:

在二级注册机构或其它机构的注册号:

The registration number of the Partner Registry or other register:

申请注册联系人:

李德锋 

研究负责人:

王立生 

Applicant:

Defeng Li 

Study leader:

Lisheng Wang 

申请注册联系人电话:

Applicant telephone:

+86 13631519583

研究负责人电话:

Study leader's telephone:

+86 13714725662

申请注册联系人传真 :

Applicant Fax:

研究负责人传真:

Study leader's fax:

申请注册联系人电子邮件:

Applicant E-mail:

ldf830712@163.com

研究负责人电子邮件:

Study leader's E-mail:

wangls168@163.com

申请单位网址(自愿提供):

Applicant website(voluntary supply):

研究负责人网址(自愿提供):

Study leader's website(voluntary supply):

申请注册联系人通讯地址:

中国广东省深圳市罗湖区东门北路1017号

研究负责人通讯地址:

中国广东省深圳市罗湖区东门北路1017号

Applicant address:

1017, Dongmen Road, Luohu District, Shenzhen , Guangdong , China

Study leader's address:

1017, Dongmen Road, Luohu District, Shenzhen , Guangdong , China

申请注册联系人邮政编码:

Applicant postcode:

518020

研究负责人邮政编码:

Study leader's postcode:

申请人所在单位:

深圳市人民医院(暨南大学第二临床医学院,南方科技大学第一附属医院)

Applicant's institution:

Shenzhen People’s Hospital?(The Second Clinical Medical College,Jinan University;The First Affiliated Hospital, Southern University of Science and Technology)

研究负责人所在单位:

Affiliation of the Leader:

是否获伦理委员会批准:

是/Yes

Approved by ethic committee:

Yes

伦理委员会批件文号:

Approved No. of ethic committee:

KY-LL--2020258

伦理委员会批件附件:

Approved file of Ethical Committee:

查看附件View

批准本研究的伦理委员会名称:

深圳市人民医院医学伦理委员会

Name of the ethic committee:

Shenzhen People's Hospital Medical Ethics Committee

伦理委员会批准日期:

Date of approved by ethic committee:

2020-04-27 00:00:00

伦理委员会联系人:

梁真

Contact Name of the ethic committee:

Zhen Liang

伦理委员会联系地址:

中国广东省深圳市罗湖区东门北路1017号

Contact Address of the ethic committee:

1017, Dongmen Road, Luohu District, Shenzhen , Guangdong , China

伦理委员会联系人电话:

Contact phone of the ethic committee:

伦理委员会联系人邮箱:

Contact email of the ethic committee:

研究实施负责(组长)单位:

深圳市人民医院(暨南大学第二临床医学院,南方科技大学第一附属医院)

Primary sponsor:

Shenzhen People’s Hospital?(The Second Clinical Medical College,Jinan University;The First Affiliated Hospital, Southern University of Science and Technology)

研究实施负责(组长)单位地址:

中国广东省深圳市罗湖区东门北路1017号

Primary sponsor's address:

1017, Dongmen Road, Luohu District, Shenzhen , Guangdong , China

试验主办单位(项目批准或申办者):

Secondary sponsor:

国家:

中国

省(直辖市):

广东

市(区县):

深圳

Country:

China

Province:

Guangdong

City:

Shenzhen

单位(医院):

深圳市人民医院(暨南大学第二临床医学院,南方科技大学第一附属医院)

具体地址:

罗湖区东门北路1017号

Institution
hospital:

Shenzhen People's Hospital (The Second Clinical Medical College, Jinan University; The First Affiliated Hospital, Southern University of Science and Technology)

Address:

1017 Dongmen Road North, Luohu District

经费或物资来源:

无额外经费支持

Source(s) of funding:

NO special funding

Target disease:

Early gastric cancer

Target disease code:

研究类型:

干预性研究

Study type:

Interventional study

研究所处阶段:

其它 

Study phase:

N/A

研究设计:

随机平行对照 

Study design:

Parallel 

研究目的:

评价空气与二氧化碳对电子胃镜检查后患者舒适度及并发症的影响效果观察。  

Objectives of Study:

Evaluation of the effect of air and carbon dioxide on the comfort and complications of patients after gastroscopy

药物成份或治疗方案详述:

 

Description for medicine or protocol of treatment in detail:

 

纳入标准:

1.18~80周岁,男女不限。
2.接受电子胃镜检查患者。
3.签署知情同意书。

Inclusion criteria

1. 18-80 years old, unlimited for men and women.
2. Patients were examined by electronic gastroscopy.
3. Sign informed consent.

排除标准:

1.有严重的心肺、神经系统疾病或处于休克、昏迷等不能耐受者。
2.疑有腹膜炎、严重腹胀者。
3.上消化道穿孔期。
4.有凝血机制障碍的出血性疾病者。
5.有腹水者。
6.有发热、急性咽喉炎、扁桃体炎者。
严重脊柱畸形。

Exclusion criteria:

1. Patients with severe cardiopulmonary and nervous system diseases or intolerable to shock and coma.
2. Suspected peritonitis and severe abdominal distention.
3. Perforation stage of upper digestive tract.
4. Patients with haemorrhagic diseases with coagulation mechanism disorders.
5. Ascites.
6. Have fever, acute pharyngitis, tonsillitis.
7.Severe spinal deformity.

研究实施时间:

Study execute time:

From 2020-09-27 00:00:00 To 2021-12-27 00:00:00  

征募观察对象时间:

Recruiting time:

From 2020-06-26 00:00:00 To 2021-09-26 00:00:00  

干预措施:

Interventions:

组别:

试验组

样本量:

158

Group:

experimental group

Sample size:

干预措施:

二氧化碳

干预措施代码:

Intervention:

Carbon dioxide

Intervention code:

组别:

对照组

样本量:

158

Group:

control group

Sample size:

干预措施:

空气

干预措施代码:

Intervention:

Air

Intervention code:

研究实施地点:

Countries of recruitment and research settings:

国家:

中国

省(直辖市):

广东 

市(区县):

深圳 

Country:

China 

Province:

Guangdong 

City:

Shenzhen 

单位(医院):

深圳市人民医院(暨南大学第二临床医学院,南方科技大学第一附属医院) 

单位级别:

三级甲等 

Institution
hospital:

Shenzhen People's Hospital (the Second Clinical Medical College of Jinan University / the First Affiliated Hospital of South University of science and Technology)

Level of the institution:

Tertiary A

测量指标:

Outcomes:

指标中文名:

Kolcaba的舒适状况量表

指标类型:

主要指标

Outcome:

Kolcab Comfort Scale

Type:

Primary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

NRS疼痛评分

指标类型:

主要指标

Outcome:

NRS pain score

Type:

Primary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

胃早癌检出率

指标类型:

主要指标

Outcome:

Detection rate of early gastric cancer

Type:

Primary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

气压伤

指标类型:

主要指标

Outcome:

Barotrauma

Type:

Primary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

呃逆次数

指标类型:

次要指标

Outcome:

Number of hiccups

Type:

Secondary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

操作时间

指标类型:

主要指标

Outcome:

Operation time

Type:

Primary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

采集人体标本:

Collecting sample(s)
from participants:

标本中文名:

组织:

Sample Name:

N/A

Tissue:

人体标本去向

其它  

说明

Fate of sample:

0thers  

Note:

征募研究对象情况:

Recruiting status:

正在进行

Recruiting

年龄范围:

Participant age:

最小 Min age 18 years
最大 Max age 80 years

性别:

男女均可

Gender:

Both

随机方法(请说明由何人用什么方法产生随机序列):

采用Excel生成随机数字,按照数字大小平均分为两组

Randomization Procedure (please state who generates the random number sequence and by what method):

Excel is used to generate random numbers, which are divided into two groups according to the number size

是否公开试验完成后的统计结果:

Calculated Results after the Study Completed public access:

公开/Public

盲法:

单盲

Blinding:

Single blind

试验完成后的统计结果(上传文件):

Calculated Results after
the Study Completed(upload file):

是否共享原始数据:

IPD sharing

Yes

共享原始数据的方式(说明:请填入公开原始数据日期和方式,如采用网络平台,需填该网络平台名称和网址):

临床试验公共管理平台(http://www.medresman.org/login.aspx)

The way of sharing IPD”(include metadata and protocol, If use web-based public database, please provide the url):

ResMan research manager(http://www.medresman.org/login.aspx)

数据采集和管理(说明:数据采集和管理由两部分组成,一为病例记录表(Case Record Form, CRF),二为电子采集和管理系统(Electronic Data Capture, EDC),如ResMan即为一种基于互联网的EDC:

使用CRF表收集数据,由3名研究员(李德锋、姚君、魏铖、)完成,并由1名研究者(王立生)进行核查,最终数据由2名研究者(师瑞月、刘婷婷)将上述数据库录入并提交至ResMan 临床试验公共管理平台(预计时间为前)

Data collection and Management (A standard data collection and management system include a CRF and an electronic data capture:

The CRF table was used to collect data, which was completed by three researchers (Li Defeng, Yao Jun, Wei Cheng) and verified by one researcher (Wang Lisheng). The final data was entered by two researchers (Shi ruiyue, Liu Tingting) and submitted to the resman clinical trial public management platform (the expected time is before)

数据与安全监察委员会:

Data and Safety Monitoring Committee:

有/Yes

注册人:

Name of Registration:

 2020-05-27 22:11:53